Hudson Buck

Prof. Dr. Hudson Buck

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Andrea Rodrigues VasconcelosAndrea Rodrigues Vasconcelos
Andrea Rodrigues Vasconcelos
LYLidia M Yshii
Lidia M Yshii
TVTania Viel
Tania Viel
HBHudson Buck
Hudson Buck
MMMark Mattson
Mark Mattson
EKElisa M Kawamoto
Elisa M Kawamoto
Systemic bacterial infections often result in enduring cognitive impairment and are a risk factor for dementia. There are currently no effective treatments for infection-induced cognitive impairment. Previous studies have shown that intermittent fasting (IF) can increase the resistance of neurons to injury and disease by stimulating adaptive cellular stress responses. However, the impact of IF on the cognitive sequelae of systemic and brain inflammation is unknown. Rats on IF for 30 days received 1 mg/kg of lipopolysaccharide (LPS) or saline intravenously. Half of the rats were subjected to behavioral tests and the other half were euthanized two hours after LPS administration and the hippocampus was dissected and frozen for analyses. Here, we report that IF ameliorates cognitive deficits in a rat model of sepsis by a mechanism involving NF-κB activation, suppression of the expression of pro-inflammatory cytokines, and enhancement of neurotrophic support. Treatment of rats with LPS resulted in deficits in cognitive performance in the Barnes maze and inhibitory avoidance tests, without changing locomotor activity, that were ameliorated in rats that had been maintained on the IF diet. IF also resulted in reduced levels of mRNAs encoding the LPS receptor TLR4 and inducible nitric oxide synthase (iNOS) in the hippocampus. Moreover, IF prevented LPS-induced elevation of IL-1α, IL-1β and TNF-α levels, and prevented the LPS-induced reduction of BDNF levels in the hippocampus. IF also significantly attenuated LPS-induced elevations of serum IL-1β, IFN-γ, RANTES, TNF-α and IL-6 levels. Taken together, our results suggest that IF induces adaptive responses in the brain and periphery that can suppress inflammation and preserve cognitive function in an animal model of systemic bacterial infection.

9 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMaressa Caldeira Morzelle
Maressa Caldeira Morzelle
JSJocelem Mastrodi Salgado
Jocelem Mastrodi Salgado
MTMilena Telles
Milena Telles
DMDanilo Mourelle
Danilo Mourelle
PBPatricia Bachiega
Patricia Bachiega
TVTania Viel
Tania Viel
Alzheimer’s disease is a chronic and degenerative condition that had no treatment until recently. The current therapeutic strategies reduce progression of the disease but are expensive and commonly cause side effects that are uncomfortable for treated patients. Functional foods to prevent and/or treat many conditions, including neurodegenerative diseases, represent a promising field of study currently gaining attention. To this end, here we demonstrate the effects of pomegranate (Punica granatum) peel extract (PPE) regarding spatial memory, biomarkers of neuroplasticity, oxidative stress and inflammation in a mouse model of neurodegeneration. Male C57Bl/6 mice were chronically infused for 35 days with amyloid-β peptide 1–42 (Aβ) or vehicle (control) using mini-osmotic pumps. Another group, also infused with Aβ, was treated with PPE (p.o.– βA+PPE, 800 mg/kg/day). Spatial memory was evaluated in the Barnes maze. Animals treated with PPE and in the control group exhibited a reduction in failure to find the escape box, a finding that was not observed in the Aβ group. The consumption of PPE reduced amyloid plaque density, increased the expression of neurotrophin BDNF and reduced the activity of acetylcholinesterase enzyme. A reduction in lipid peroxidation and in the concentration of the pro-inflammatory cytokine TNF-α was also observed in the PPE group. No hepatic lesions were observed in animals treated with PPE. In conclusion, administration of pomegranate peel extract has neuroprotective effects involving multiple mechanisms to prevent establishment and progression of the neurodegenerative process induced by infusion with amyloid-β peptide in mice.

1 December 2001 in Autonomic Neuroscience
Verified
Journal Article
Closed access
CCCristofer Andre Caous
Cristofer Andre Caous
HBHudson Buck
Hudson Buck
CLCharles Julian Lindsey
Charles Julian Lindsey

25 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMarielza Andrade Nunes
Marielza Andrade Nunes
NSNatalia Mendes Schöwe
Natalia Mendes Schöwe
KMKarla Cristina Monteiro-Silva
Karla Cristina Monteiro-Silva
TBTiciana Baraldi-Tornisielo
Ticiana Baraldi-Tornisielo
SSSuzzanna Ingryd Gonçalves Souza
Suzzanna Ingryd Gonçalves Souza
HBHudson Buck
Hudson Buck
The use of lithium is well established in bipolar disorders and the benefits are being demonstrated in neurodegenerative disorders. Recently, our group showed that treatment with microdose lithium stabilized the cognitive deficits observed in Alzheimer’s disease (AD) patients. In order to verify the lithium microdose potential in preventing the disease development, the aim of this work was to verify the effects of chronic treatment with microdose lithium given before and after the appearance of symptoms in a mouse model of a disease similar to AD. Transgenic mice (Cg-Tg(PDGFB-APPSwInd)20Lms/2J) and their non-transgenic litter mate genetic controls were treated with lithium carbonate (1.2 mg/Kg/day in drinking water) for 16 or 8 months starting at two and ten months of age, respectively. Similar groups were treated with water. At the end of treatments, both lithium treated transgenic groups and non-transgenic mice showed no memory disruption, different from what was observed in the water treated transgenic group. Transgenic mice treated with lithium since two months of age showed decreased number of senile plaques, no neuronal loss in cortex and hippocampus and increased BDNF density in cortex, when compared to non-treated transgenic mice. It is suitable to conclude that these data support the use of microdose lithium in the prevention and treatment of Alzheimer’s disease, once the neurohistopathological characteristics of the disease were modified and the memory of transgenic animals was maintained.

1 December 2008 in Neurobiology of Aging
Verified
Journal Article
Closed access
TVTania Viel
Tania Viel
ACAriadiny Lima Caetano
Ariadiny Lima Caetano
ANAntonia Gladys Nasello
Antonia Gladys Nasello
CLCarmen Lucia Lancelotti
Carmen Lucia Lancelotti
VNViviane Abreu Nunes
Viviane Abreu Nunes
HBHudson Buck
Hudson Buck

1 March 2001 in Autonomic Neuroscience
Verified
Journal Article
Closed access
HBHudson Buck
Hudson Buck
CCCristofer Andre Caous
Cristofer Andre Caous
CLCharles Julian Lindsey
Charles Julian Lindsey